Viewing Study NCT00759200


Ignite Creation Date: 2025-12-18 @ 3:59 AM
Ignite Modification Date: 2025-12-23 @ 10:01 PM
Study NCT ID: NCT00759200
Status:
Last Update Posted:
First Post:
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients
Sponsor:
Organization:

Study Modules

Contacts Locations Module Design Module Eligibility Module Outcomes Module References Module